Page last updated: 2024-08-26
rfcnu and Thrombopenia
rfcnu has been researched along with Thrombopenia in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| de Jager, R; De Vassal, F; Gouveia, J; Imbach, JL; Jasmin, C; MacDonald, JS; Machover, D; Mathe, G; Misset, JL; Musset, M; Ribaud, P; Schein, P; Schwarzenberg, L; Serrou, B | 1 |
| Belpomme, D; De Vassal, F; Hayat, M; Imbach, JL; Jasmin, C; Machover, D; Mathé, G; Misset, JL; Montero, JL; Musset, M; Ribaud, P; Schwarzenberg, L; Serrou, B | 1 |
Trials
1 trial(s) available for rfcnu and Thrombopenia
| Article | Year |
|---|---|
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Nitrosourea Compounds; Thrombocytopenia | 1977 |
Other Studies
1 other study(ies) available for rfcnu and Thrombopenia
| Article | Year |
|---|---|
Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.
Topics: Adult; Aged; Antineoplastic Agents; Digestive System Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Thrombocytopenia | 1982 |